Search research articles
Contact Us
Filters
Showing results (161-170 of 205) with videos related to
Page
of 21
Sort By:
Journal of Hypertension
|
May 17, 2023
Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant
Laura E J Peeters, Dennis A Hesselink, Melvin Lafeber, et al.
Clinical Pharmacokinetics
|
September 27, 2024
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Bram C Agema, Tolra Kocher, Ayşenur B Öztürk, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
September 29, 2019
In Vitro Recovery of Sufentanil, Midazolam, Propofol, and Methylprednisolone in Pediatric Cardiopulmonary Bypass Systems
Annewil van Saet, Gerdien A Zeilmaker-Roest, Marloes P J van Hoeven, et al.
British Journal of Clinical Pharmacology
|
August 29, 2025
External validation of a therapeutic window for risperidone in children with autism spectrum disorder
Rebecca A Hermans, Kathalijne Bruens, Karin M Egberts, et al.
Nephron
|
December 23, 2014
The effects of kidney transplantation on sleep, melatonin, circadian rhythm and quality of life in kidney transplant recipients and living donors
Marije Russcher, J Elsbeth Nagtegaal, S Azam Nurmohamed, et al.
Therapeutic Drug Monitoring
|
July 4, 2019
Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring
Sara Capiau, Herman Veenhof, Remco A Koster, et al.
Journal of Pain and Symptom Management
|
August 30, 2024
Optimizing the Dosing Regimen During Rotation From Subcutaneous to Transdermal Administration of Fentanyl
Bram C Agema, Kim Vrielink, Esther Oomen-de Hoop, et al.
Therapeutic Advances in Medical Oncology
|
June 9, 2022
Improving the tolerability of osimertinib by identifying its toxic limit
Bram C Agema, G D Marijn Veerman, Christi M J Steendam, et al.
Pharmaceutics
|
December 28, 2021
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients
Femke de Velde, Brenda C M de Winter, Michael N Neely, et al.
European Urology Oncology
|
November 4, 2023
Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia
Bram C Agema, Stefan A J Buck, Mano Viskil, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 205) with videos related to
Sort By:
Page
of 21
Journal of Hypertension
|
May 17, 2023
Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant
Laura E J Peeters, Dennis A Hesselink, Melvin Lafeber, et al.
Clinical Pharmacokinetics
|
September 27, 2024
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Bram C Agema, Tolra Kocher, Ayşenur B Öztürk, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
September 29, 2019
In Vitro Recovery of Sufentanil, Midazolam, Propofol, and Methylprednisolone in Pediatric Cardiopulmonary Bypass Systems
Annewil van Saet, Gerdien A Zeilmaker-Roest, Marloes P J van Hoeven, et al.
British Journal of Clinical Pharmacology
|
August 29, 2025
External validation of a therapeutic window for risperidone in children with autism spectrum disorder
Rebecca A Hermans, Kathalijne Bruens, Karin M Egberts, et al.
Nephron
|
December 23, 2014
The effects of kidney transplantation on sleep, melatonin, circadian rhythm and quality of life in kidney transplant recipients and living donors
Marije Russcher, J Elsbeth Nagtegaal, S Azam Nurmohamed, et al.
Therapeutic Drug Monitoring
|
July 4, 2019
Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring
Sara Capiau, Herman Veenhof, Remco A Koster, et al.
Journal of Pain and Symptom Management
|
August 30, 2024
Optimizing the Dosing Regimen During Rotation From Subcutaneous to Transdermal Administration of Fentanyl
Bram C Agema, Kim Vrielink, Esther Oomen-de Hoop, et al.
Therapeutic Advances in Medical Oncology
|
June 9, 2022
Improving the tolerability of osimertinib by identifying its toxic limit
Bram C Agema, G D Marijn Veerman, Christi M J Steendam, et al.
Pharmaceutics
|
December 28, 2021
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients
Femke de Velde, Brenda C M de Winter, Michael N Neely, et al.
European Urology Oncology
|
November 4, 2023
Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia
Bram C Agema, Stefan A J Buck, Mano Viskil, et al.
Page
of 21